Ozone IV therapy is a procedure in which a small amount of your blood is drawn, mixed with medical-grade ozone gas, and then reinfused into your body. The most common form, called major autohemotherapy (MAH), has been used in complementary medicine for decades to address conditions ranging from chronic pain to infections. It remains controversial: while a growing body of clinical research shows benefits for specific conditions, the FDA has not approved ozone as a medical treatment in the United States, and serious complications, though rare, have been documented.
How the Procedure Works
During a standard MAH session, a practitioner draws 50 to 100 milliliters of blood from a vein into a sterile vacuum bottle. An ozone-oxygen gas mixture is then bubbled through the blood using sodium citrate as an anticoagulant. The ozone concentration typically ranges from 10 to 40 micrograms per milliliter of blood, depending on the condition being treated and the patient’s tolerance. Once the blood has been exposed to the gas, it’s immediately reinfused through the same IV line in a closed system.
The whole process takes about 30 to 45 minutes. Some clinics offer “multi-pass” sessions, where this cycle is repeated several times in a single visit. A single-pass session is the simplest version, while multi-pass protocols (up to 10 passes) are marketed for more intensive treatment goals.
What Ozone Does Inside the Body
The core idea behind ozone therapy is that introducing a controlled dose of ozone creates a brief, mild burst of oxidative stress in the blood. This sounds counterintuitive, since oxidative stress is usually something the body works to prevent. But the dose matters. At low concentrations, ozone activates a protective pathway centered on a protein called Nrf2, which acts like a master switch for the body’s antioxidant defenses.
When Nrf2 is activated, it travels into the cell nucleus and triggers the production of a wide range of protective enzymes. These include superoxide dismutase, catalase, and glutathione peroxidase, all of which neutralize harmful free radicals and reduce inflammation. Nrf2 activation also suppresses a different pathway (NFκB) that drives inflammatory responses. So the paradox of ozone therapy is that a small oxidative challenge can actually leave the body in a more anti-inflammatory, antioxidant state than before.
This is a dose-dependent effect. Too much ozone overwhelms those defenses and causes tissue damage. That’s why clinical guidelines emphasize staying within the 10 to 40 microgram range for systemic applications.
Conditions It’s Used For
Ozone therapy has been studied across a surprisingly wide range of conditions, though the quality of evidence varies significantly.
The strongest clinical data exists for musculoskeletal pain. For low back pain caused by herniated discs, success rates between 54% and 86% have been reported with direct ozone injection into the disc space. In a randomized trial for fibromyalgia, 35% of patients treated with ozone autohemotherapy showed excellent improvement. Research published in The Lancet Regional Health has also noted meaningful results for multiple sclerosis and chronic fatigue syndrome, with patients experiencing significant reductions in fatigue after autohemotherapy.
For circulatory problems, one study on chronic limb ischemia found that 80% of patients receiving ozone showed marked improvement, compared to 43.8% with conventional vasodilation therapy. In dry age-related macular degeneration, 66.6% of treated patients improved their visual acuity by more than two standardized lines, versus 30.4% in the control group.
Ozone also has well-documented antimicrobial properties. Topical ozone applications (ozonated oils and water, rather than IV) have shown strong results for skin infections, wound healing, fungal conditions, and oral diseases. In a controlled phase III trial for athlete’s foot, ozonated sunflower oil produced a complete, stable cure in 90.5% of patients after three months. More recently, ozone therapy gained attention as an adjunct treatment during the COVID-19 pandemic and for post-COVID symptoms.
What Sessions Cost and Look Like
A basic single-session MAH treatment typically costs $200 to $300. Multi-pass sessions run higher: three to four passes cost around $450, while the most intensive protocols (nine to ten passes) can reach $900 per session. Prices vary by location, with major metropolitan areas generally charging more.
Most practitioners recommend weekly sessions, though some patients receive treatment twice per week depending on their symptoms. Because ozone therapy has a cumulative effect, a typical course runs five to ten sessions before the full benefits are apparent. There is usually no downtime after a session, and most people return to normal activities immediately.
Insurance does not cover ozone therapy in the United States. The entire cost is out of pocket, which means a full treatment course can range from roughly $1,000 to $9,000 depending on the protocol.
Safety and Known Risks
When performed by trained practitioners using proper equipment and dosing within established guidelines, ozone therapy has a relatively low complication rate. Most people tolerate sessions without significant side effects.
The most serious documented risk is air embolism, where gas bubbles enter the bloodstream and travel to the brain or lungs. In one published case report, a 36-year-old woman developed chest pain, lost consciousness, and had a seizure shortly after IV ozone therapy. Imaging revealed multiple small strokes in her thalamus and cerebellum, consistent with an embolic event. Patients with a patent foramen ovale (a small hole between the heart’s upper chambers, present in roughly 25% of adults) may face elevated risk. Ozone-induced encephalopathy, a form of brain injury from direct ozone toxicity, has also been reported, though rarely.
These severe outcomes are uncommon, but they underscore why the procedure requires careful technique. Direct injection of ozone gas into a vein (as opposed to the autohemotherapy method, where blood is ozonated outside the body and then returned) carries a higher risk profile.
Who Should Not Receive Ozone Therapy
Several conditions rule out ozone therapy entirely. The most important is G6PD deficiency (also known as favism), a genetic enzyme deficiency affecting roughly 400 million people worldwide. Without adequate G6PD, red blood cells cannot handle the oxidative stress ozone creates, leading to potentially dangerous breakdown of red blood cells.
Other contraindications include pregnancy, recent heart attack, active bleeding from any organ, uncontrolled hyperthyroidism, severe anemia, low platelet counts, seizure disorders, severe myasthenia gravis, and acute alcohol intoxication. Anyone considering ozone therapy should be screened for G6PD deficiency beforehand, as many people carry the trait without knowing it.
Regulatory Status in the United States
The FDA has not approved ozone for any medical use in the United States. The agency has specifically warned against ozone-generating devices in other contexts, citing reports of headaches, asthma attacks, and breathing difficulty from ozone exposure. No ozone therapy device has received FDA clearance or authorization for treating disease.
This does not mean ozone therapy is illegal. Practitioners in many states offer it as an off-label or complementary treatment, often in integrative medicine clinics. In contrast, several European countries and Cuba have more established regulatory frameworks for medical ozone use, and much of the clinical research originates from these regions. The gap between the growing body of published evidence and the lack of formal FDA recognition is one of the central tensions in the field, and it means the burden of evaluating practitioners and protocols falls largely on the patient.